Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: A meta-analysis from randomized controlled trails

This meta-analysis aimed to assess the efficiency of intravenous administration of zoledronic acid on reducing femoral periprosthetic bone mineral density loss in patients undergoing primary total hip arthroplasty (THA).
Source: International Journal of Surgery - Category: Surgery Authors: Tags: Review Source Type: research
More News: Reclast | Surgery | Zometa